$SEEL
Seelos Therapeutics Inc

2014 Q4 Form 10-Q Financial Statement

#000101749114000103 Filed on November 10, 2014

View on sec.gov

Income Statement

Concept 2014 Q4 2014 Q3 2013 Q3
Revenue $1.907M $1.898M $28.00K
YoY Change 426.8% 6678.57% -99.43%
Cost Of Revenue $360.0K $0.00 $15.00K
YoY Change 500.0% -100.0% -99.06%
Gross Profit $1.549M $1.413M $13.00K
YoY Change 418.06% 10769.23% -99.61%
Gross Profit Margin 81.23% 74.45% 46.43%
Selling, General & Admin $2.760M $2.720M $2.870M
YoY Change -11.25% -5.23% -35.33%
% of Gross Profit 178.18% 192.5% 22076.92%
Research & Development $15.87M $1.876M $919.0K
YoY Change 1159.52% 104.13% -54.03%
% of Gross Profit 1024.53% 132.77% 7069.23%
Depreciation & Amortization $70.00K $60.00K $20.00K
YoY Change 250.0% 200.0% 100.0%
% of Gross Profit 4.52% 4.25% 153.85%
Operating Expenses $18.63M $4.595M $3.176M
YoY Change 326.32% 44.68% -43.58%
Operating Profit -$17.08M -$3.182M -$3.163M
YoY Change 319.58% 0.6% 36.04%
Interest Expense -$120.0K -$44.00K -$174.0K
YoY Change -104.82% -74.71% 138.36%
% of Operating Profit
Other Income/Expense, Net -$10.00K $50.00K -$36.00K
YoY Change -92.86% -238.89% -185.71%
Pretax Income -$17.29M -$3.130M -$3.200M
YoY Change 954.27% -2.19% 12.04%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$17.29M -$3.113M -$2.985M
YoY Change 1185.35% 4.29% 19.69%
Net Earnings / Revenue -906.55% -164.01% -10660.71%
Basic Earnings Per Share -$0.40 -$0.08
Diluted Earnings Per Share -$0.40 -$0.08 -$21.36M
COMMON SHARES
Basic Shares Outstanding 43.62M shares 38.10M shares 36.98M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2014 Q4 2014 Q3 2013 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $11.40M $16.11M $20.62M
YoY Change -46.75% -21.87% 22.3%
Cash & Equivalents $11.40M $16.11M $20.62M
Short-Term Investments
Other Short-Term Assets $940.0K $1.110M $670.0K
YoY Change 104.35% 65.67% -88.12%
Inventory $275.0K $321.0K $338.0K
Prepaid Expenses
Receivables $678.0K $829.0K $35.00K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $13.29M $18.37M $21.66M
YoY Change -40.31% -15.19% -19.02%
LONG-TERM ASSETS
Property, Plant & Equipment $1.358M $1.319M $549.0K
YoY Change 42.2% 140.26% 176.64%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $162.0K $106.0K $90.00K
YoY Change 78.02% 17.78% -93.13%
Total Long-Term Assets $1.520M $1.425M $639.0K
YoY Change 45.32% 123.0% -95.44%
TOTAL ASSETS
Total Short-Term Assets $13.29M $18.37M $21.66M
Total Long-Term Assets $1.520M $1.425M $639.0K
Total Assets $14.81M $19.80M $22.30M
YoY Change -36.47% -11.23% -45.27%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $860.0K $1.220M $620.0K
YoY Change -7.53% 96.77% -69.46%
Accrued Expenses $4.555M $1.825M $2.180M
YoY Change 114.96% -16.28% -65.01%
Deferred Revenue
YoY Change
Short-Term Debt $150.0K $1.200M $1.440M
YoY Change -94.23% -16.67% -64.0%
Long-Term Debt Due $0.00
YoY Change
Total Short-Term Liabilities $6.906M $6.386M $8.400M
YoY Change -41.28% -23.98% -43.17%
LONG-TERM LIABILITIES
Long-Term Debt $4.630M $0.00 $1.100M
YoY Change -100.0%
Other Long-Term Liabilities $358.0K $58.00K $127.0K
YoY Change -38.06% -54.33% -40.34%
Total Long-Term Liabilities $358.0K $58.00K $127.0K
YoY Change -38.06% -54.33% -40.34%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.906M $6.386M $8.400M
Total Long-Term Liabilities $358.0K $58.00K $127.0K
Total Liabilities $12.89M $7.800M $10.35M
YoY Change 4.47% -24.67% -39.84%
SHAREHOLDERS EQUITY
Retained Earnings -$289.9M -$272.6M -$266.7M
YoY Change 8.13% 2.19% 15.22%
Common Stock $291.8M $284.6M $278.7M
YoY Change 4.56% 2.11% 9.28%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.919M $12.00M $11.95M
YoY Change
Total Liabilities & Shareholders Equity $14.81M $19.80M $22.30M
YoY Change -36.47% -11.23% -45.27%

Cashflow Statement

Concept 2014 Q4 2014 Q3 2013 Q3
OPERATING ACTIVITIES
Net Income -$17.29M -$3.113M -$2.985M
YoY Change 1185.35% 4.29% 19.69%
Depreciation, Depletion And Amortization $70.00K $60.00K $20.00K
YoY Change 250.0% 200.0% 100.0%
Cash From Operating Activities -$9.120M -$4.080M -$4.330M
YoY Change -907.08% -5.77% 49.31%
INVESTING ACTIVITIES
Capital Expenditures -$80.00K -$70.00K $0.00
YoY Change -82.22% -100.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $170.0K
YoY Change -100.0% -100.0% -91.98%
Cash From Investing Activities -$80.00K -$60.00K $160.0K
YoY Change -75.0% -137.5% -90.53%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 4.490M 2.840M 30.00K
YoY Change -15066.67% 9366.67% 200.0%
NET CHANGE
Cash From Operating Activities -9.120M -4.080M -4.330M
Cash From Investing Activities -80.00K -60.00K 160.0K
Cash From Financing Activities 4.490M 2.840M 30.00K
Net Change In Cash -4.710M -1.300M -4.140M
YoY Change -703.85% -68.6% 245.0%
FREE CASH FLOW
Cash From Operating Activities -$9.120M -$4.080M -$4.330M
Capital Expenditures -$80.00K -$70.00K $0.00
Free Cash Flow -$9.040M -$4.010M -$4.330M
YoY Change -672.15% -7.39% 75.3%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q3 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
1221000 USD
CY2013Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
926000 USD
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
59000 USD
CY2014Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
829000 USD
us-gaap Accretion Expense
AccretionExpense
0 USD
us-gaap Accretion Expense
AccretionExpense
242000 USD
us-gaap Accretion Expense Including Asset Retirement Obligations
AccretionExpenseIncludingAssetRetirementObligations
128000 USD
us-gaap Accretion Expense Including Asset Retirement Obligations
AccretionExpenseIncludingAssetRetirementObligations
192000 USD
CY2013Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
952000 USD
CY2014Q3 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
853000 USD
CY2013Q4 us-gaap Accrued Environmental Loss Contingencies Current
AccruedEnvironmentalLossContingenciesCurrent
168000 USD
CY2014Q3 us-gaap Accrued Environmental Loss Contingencies Current
AccruedEnvironmentalLossContingenciesCurrent
131000 USD
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2119000 USD
CY2014Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1825000 USD
CY2013Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
997000 USD
CY2014Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
623000 USD
CY2013Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
279000000 USD
CY2014Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
284520000 USD
CY2013 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
700000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1456000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
200000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
400000 USD
CY2014Q3 us-gaap Assets
Assets
19796000 USD
CY2013Q4 us-gaap Assets
Assets
23310000 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
22264000 USD
CY2014Q3 us-gaap Assets Current
AssetsCurrent
18371000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21405000 USD
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16109000 USD
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20619000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15130000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-5296000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
5489000 USD
us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
675000 USD
us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
1500000 USD
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-144000 USD
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
16000 USD
CY2014Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
37541404 shares
CY2014Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
40023686 shares
CY2014Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
40023686 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
37541404 shares
CY2014Q3 us-gaap Common Stock Value
CommonStockValue
40000 USD
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
38000 USD
CY2014Q3 us-gaap Contracts Revenue
ContractsRevenue
0 USD
CY2013Q3 us-gaap Contracts Revenue
ContractsRevenue
28000 USD
us-gaap Contracts Revenue
ContractsRevenue
0 USD
us-gaap Contracts Revenue
ContractsRevenue
1480000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
770000 USD
us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
-131000 USD
CY2013Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
2600000 USD
CY2014Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
1203000 USD
CY2014Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
485000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
560000 USD
CY2013Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
0 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
0 USD
us-gaap Cost Of Services
CostOfServices
2568000 USD
us-gaap Cost Of Services
CostOfServices
0 USD
CY2013Q3 us-gaap Cost Of Services
CostOfServices
15000 USD
CY2014Q3 us-gaap Cost Of Services
CostOfServices
0 USD
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
1737000 USD
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
0 USD
CY2013 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
1250000 USD
CY2013Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
2750000 USD
CY2014Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1225000 USD
CY2013Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
150000 USD
CY2014Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
22000 USD
CY2013 us-gaap Debtor Reorganization Items Write Off Of Deferred Financing Costs And Debt Discounts
DebtorReorganizationItemsWriteOffOfDeferredFinancingCostsAndDebtDiscounts
200000 USD
us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
641000 USD
CY2013Q3 us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
0 USD
CY2014Q3 us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
0 USD
us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
846000 USD
CY2014Q3 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
356000 USD
CY2013Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
487000 USD
CY2014Q3 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
180000 USD
CY2013Q4 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
184000 USD
CY2014Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1284000 USD
CY2013Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1800000 USD
CY2014Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
1000000 USD
CY2013Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
0 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
102000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
57000 USD
CY2014Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
0 USD
CY2013Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
517000 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.47
CY2013Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.08
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.12
CY2014Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.08
CY2014Q3 us-gaap Escrow Deposit
EscrowDeposit
300000 USD
us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
-517000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-239000 USD
us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
243000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-400000 USD
us-gaap Gross Profit
GrossProfit
-419000 USD
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-517000 USD
CY2013Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
517000 USD
CY2014Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
0 USD
CY2014Q3 us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
0 USD
CY2013Q3 us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
534000 USD
us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
910000 USD
us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
534000 USD
CY2014Q3 us-gaap Gain Loss On Sale Of Stock In Subsidiary Or Equity Method Investee
GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee
0 USD
CY2013Q3 us-gaap Gain Loss On Sale Of Stock In Subsidiary Or Equity Method Investee
GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee
75000 USD
us-gaap Gain Loss On Sale Of Stock In Subsidiary Or Equity Method Investee
GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee
180000 USD
us-gaap Gain Loss On Sale Of Stock In Subsidiary Or Equity Method Investee
GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee
50000 USD
us-gaap Gain Or Loss On Sale Of Stock In Subsidiary
GainOrLossOnSaleOfStockInSubsidiary
50000 USD
us-gaap Gain Or Loss On Sale Of Stock In Subsidiary
GainOrLossOnSaleOfStockInSubsidiary
180000 USD
CY2014Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2719000 USD
CY2013Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2866000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8655000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10446000 USD
CY2013Q3 us-gaap Gross Profit
GrossProfit
13000 USD
CY2014Q3 us-gaap Gross Profit
GrossProfit
1413000 USD
us-gaap Gross Profit
GrossProfit
6792000 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-14235000 USD
CY2014Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-3132000 USD
CY2013Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-3199000 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-5189000 USD
us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.43
CY2014Q3 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.08
CY2013Q3 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.09
us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.14
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
691000 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-1358000 USD
CY2013Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
214000 USD
CY2014Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
19000 USD
CY2014Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare
0.00
CY2013Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare
0.01
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare
-0.04
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare
0.02
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1232000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
295000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-276000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
338000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-15000 USD
us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
-723000 USD
us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
-99000 USD
us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
-165000 USD
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
15000 USD
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-1000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-29000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
181000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
598000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
63000 USD
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
280000 USD
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
0 USD
CY2013Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-174000 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-220000 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-618000 USD
CY2014Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-44000 USD
CY2013Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
0 USD
CY2014Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
92000 USD
CY2014Q3 us-gaap Inventory Net
InventoryNet
321000 USD
CY2013Q4 us-gaap Inventory Net
InventoryNet
336000 USD
CY2013Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
209000 USD
CY2014Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
160000 USD
CY2013Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
127000 USD
CY2014Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
69000 USD
CY2013Q4 us-gaap Liabilities
Liabilities
12338000 USD
CY2014Q3 us-gaap Liabilities
Liabilities
7800000 USD
CY2014Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
19796000 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
23310000 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
11760000 USD
CY2014Q3 us-gaap Liabilities Current
LiabilitiesCurrent
6386000 USD
CY2014Q3 us-gaap Licenses Revenue
LicensesRevenue
1500000 USD
us-gaap Licenses Revenue
LicensesRevenue
6954000 USD
us-gaap Licenses Revenue
LicensesRevenue
669000 USD
CY2013Q3 us-gaap Licenses Revenue
LicensesRevenue
0 USD
us-gaap Net Cash Provided By Used In Discontinued Operations
NetCashProvidedByUsedInDiscontinuedOperations
691000 USD
us-gaap Net Cash Provided By Used In Discontinued Operations
NetCashProvidedByUsedInDiscontinuedOperations
1356000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-17000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
5018000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
3376000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
16623000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-450000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
3438000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-15928000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-8913000 USD
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-2985000 USD
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
-3113000 USD
us-gaap Net Income Loss
NetIncomeLoss
-4498000 USD
us-gaap Net Income Loss
NetIncomeLoss
-15593000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-858000 USD
CY2014Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
50000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
291000 USD
CY2013Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-36000 USD
CY2014Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 Segment
us-gaap Operating Expenses
OperatingExpenses
12272000 USD
CY2013Q3 us-gaap Operating Expenses
OperatingExpenses
3176000 USD
CY2014Q3 us-gaap Operating Expenses
OperatingExpenses
4595000 USD
us-gaap Operating Expenses
OperatingExpenses
12958000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-13377000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-5480000 USD
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3163000 USD
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3182000 USD
CY2013Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
472000 USD
CY2014Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
223000 USD
CY2014Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
106000 USD
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
91000 USD
CY2014Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
58000 USD
CY2013Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
91000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
0 USD
CY2013Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
138000 USD
CY2014Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
94000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
511000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-240000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
42000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
119000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
500000 USD
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2014Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2014Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2013Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2014Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
730000 USD
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
132000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
16612000 USD
us-gaap Proceeds From Repayments Of Restricted Cash Financing Activities
ProceedsFromRepaymentsOfRestrictedCashFinancingActivities
0 USD
us-gaap Proceeds From Repayments Of Restricted Cash Financing Activities
ProceedsFromRepaymentsOfRestrictedCashFinancingActivities
-50000 USD
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-1525000 USD
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
0 USD
CY2013 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
8000000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
3657000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
us-gaap Proceeds From Sales Of Business Affiliate And Productive Assets
ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets
50000 USD
us-gaap Proceeds From Sales Of Business Affiliate And Productive Assets
ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets
180000 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
46000 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 USD
CY2014Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1319000 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
955000 USD
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
35000 USD
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
25000 USD
CY2013Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
919000 USD
CY2014Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1876000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5423000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3867000 USD
CY2014Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
382000 USD
CY2013Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
332000 USD
CY2014Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-272564000 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-268066000 USD
CY2014Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
398000 USD
CY2013Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
0 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
398000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
0 USD
CY2014Q3 us-gaap Sales Revenue Net
SalesRevenueNet
1898000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
2149000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
7352000 USD
CY2013Q3 us-gaap Sales Revenue Net
SalesRevenueNet
28000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1622000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1456000 USD
us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
486923 shares
CY2013 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
486923 shares
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
5018000 USD
us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
42000 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
10972000 USD
CY2014Q3 us-gaap Stockholders Equity
StockholdersEquity
11996000 USD
apri Stock Returned From Contract Settlement Value
StockReturnedFromContractSettlementValue
910000 USD
dei Amendment Flag
AmendmentFlag
false
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
33361000 shares
CY2013Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
37004000 shares
CY2014Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
39059000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
38282000 shares
CY2014Q3 apri Deliverables In Arrangement
DeliverablesInArrangement
2 deliverable
apri Increase Decrease In Deferred Revenue Long Term
IncreaseDecreaseInDeferredRevenueLongTerm
0 USD
apri Increase Decrease In Deferred Revenue Long Term
IncreaseDecreaseInDeferredRevenueLongTerm
1000000 USD
apri Increase Decrease In Short Term Liability Arising From Deconsolidation Of Subsidiaries
IncreaseDecreaseInShortTermLiabilityArisingFromDeconsolidationOfSubsidiaries
-2000000 USD
apri Increase Decrease In Short Term Liability Arising From Deconsolidation Of Subsidiaries
IncreaseDecreaseInShortTermLiabilityArisingFromDeconsolidationOfSubsidiaries
0 USD
apri Increase Decreasein Deferred Revenue Short Term
IncreaseDecreaseinDeferredRevenueShortTerm
-248000 USD
apri Increase Decreasein Deferred Revenue Short Term
IncreaseDecreaseinDeferredRevenueShortTerm
-516000 USD
apri Other Noncash Investingand Financing Items Releaseof Obligations Relatedto Short Term Loans
OtherNoncashInvestingandFinancingItemsReleaseofObligationsRelatedtoShortTermLoans
51000 USD
apri Other Noncash Investingand Financing Items Releaseof Obligations Relatedto Short Term Loans
OtherNoncashInvestingandFinancingItemsReleaseofObligationsRelatedtoShortTermLoans
0 USD
CY2013Q4 apri Research And Development Accrued Expense
ResearchAndDevelopmentAccruedExpense
298000 USD
CY2014Q3 apri Research And Development Accrued Expense
ResearchAndDevelopmentAccruedExpense
668000 USD
CY2013Q4 apri Short Term Liability Arising From Deconsolidation Of French Subsidiaries
ShortTermLiabilityArisingFromDeconsolidationOfFrenchSubsidiaries
2846000 USD
CY2014Q3 apri Short Term Liability Arising From Deconsolidation Of French Subsidiaries
ShortTermLiabilityArisingFromDeconsolidationOfFrenchSubsidiaries
0 USD
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
dei Document Period End Date
DocumentPeriodEndDate
2014-09-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001017491
CY2014Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
43623756 shares
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
APRICUS BIOSCIENCES, INC.
dei Trading Symbol
TradingSymbol
APRI

Files In Submission

Name View Source Status
0001017491-14-000103-index-headers.html Edgar Link pending
0001017491-14-000103-index.html Edgar Link pending
0001017491-14-000103.txt Edgar Link pending
0001017491-14-000103-xbrl.zip Edgar Link pending
apri-20140930.xml Edgar Link completed
apri-20140930.xsd Edgar Link pending
apri-20140930_cal.xml Edgar Link unprocessable
apri-20140930_def.xml Edgar Link unprocessable
apri-20140930_lab.xml Edgar Link unprocessable
apri-20140930_pre.xml Edgar Link unprocessable
apri-201493010xq.htm Edgar Link pending
apri-2014930xex311.htm Edgar Link pending
apri-2014930xex312.htm Edgar Link pending
apri-2014930xex321.htm Edgar Link pending
apri-2014930xex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending